Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    iCo-007
Show Display Options
Rank Status Study
1 Completed Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
Condition: Diffuse Diabetic Macular Edema
Intervention: Drug: iCo-007 Intravitreal Injection
2 Unknown  A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Condition: Diabetic Macular Edema
Interventions: Drug: iCo-007 350 mcg;   Drug: iCo-007 700 mcg;   Drug: iCo-007 350 mcg Plus Laser;   Drug: Ranibizumab Plus iCo-007 350 mcg

Study has passed its completion date and status has not been verified in more than two years.